Tags

Type your tag names separated by a space and hit enter

Blood lead levels in young children--United States and selected states, 1996-1999.
MMWR Morb Mortal Wkly Rep. 2000 Dec 22; 49(50):1133-7.MM

Abstract

Lead exposure adversely affects the cognitive development and behavior of young children (1). For children aged < 6 years, CDC has defined an elevated blood lead level (BLL) as > or = 10 microg/dL, but evidence exists for subtle effects at lower levels (2). Data from CDC's Third National Health and Nutrition Examination Survey, Phase 2 (1991-1994) (NHANES) showed that average BLLs in children had decreased approximately 80% since the late 1970s but that elevated BLLs remained more common among low-income children, urban children, and those living in older housing (3,4). Although these data provide national estimates of the prevalence of elevated BLLs among children, they do not provide information at the state or local level. To target prevention efforts and monitor progress toward reducing BLLs at the state and local level, CDC's Childhood Blood Lead Surveillance (CBLS) program supports state blood lead surveillance programs on the basis of blood lead tests from public and private clinical laboratories. This report summarizes data on BLLs in children aged 1-5 years from NHANES data collected in 1999 and children aged < 6 years from state surveillance data provided to CDC by 19 state surveillance programs during 1996-1998. The findings indicate that, despite the decreases in mean BLL among children, the problem remains concentrated on a local level. Surveillance efforts should be used to target screening efforts to communities at highest risk.

Authors

Pub Type(s)

Journal Article

Language

eng

PubMed ID

11190117

Citation

Centers for Disease Control and Prevention (CDC). "Blood Lead Levels in Young children--United States and Selected States, 1996-1999." MMWR. Morbidity and Mortality Weekly Report, vol. 49, no. 50, 2000, pp. 1133-7.
Centers for Disease Control and Prevention (CDC). Blood lead levels in young children--United States and selected states, 1996-1999. MMWR Morb Mortal Wkly Rep. 2000;49(50):1133-7.
Centers for Disease Control and Prevention (CDC). (2000). Blood lead levels in young children--United States and selected states, 1996-1999. MMWR. Morbidity and Mortality Weekly Report, 49(50), 1133-7.
Centers for Disease Control and Prevention (CDC). Blood Lead Levels in Young children--United States and Selected States, 1996-1999. MMWR Morb Mortal Wkly Rep. 2000 Dec 22;49(50):1133-7. PubMed PMID: 11190117.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Blood lead levels in young children--United States and selected states, 1996-1999. A1 - ,, PY - 2001/2/24/pubmed PY - 2001/2/28/medline PY - 2001/2/24/entrez SP - 1133 EP - 7 JF - MMWR. Morbidity and mortality weekly report JO - MMWR Morb Mortal Wkly Rep VL - 49 IS - 50 N2 - Lead exposure adversely affects the cognitive development and behavior of young children (1). For children aged < 6 years, CDC has defined an elevated blood lead level (BLL) as > or = 10 microg/dL, but evidence exists for subtle effects at lower levels (2). Data from CDC's Third National Health and Nutrition Examination Survey, Phase 2 (1991-1994) (NHANES) showed that average BLLs in children had decreased approximately 80% since the late 1970s but that elevated BLLs remained more common among low-income children, urban children, and those living in older housing (3,4). Although these data provide national estimates of the prevalence of elevated BLLs among children, they do not provide information at the state or local level. To target prevention efforts and monitor progress toward reducing BLLs at the state and local level, CDC's Childhood Blood Lead Surveillance (CBLS) program supports state blood lead surveillance programs on the basis of blood lead tests from public and private clinical laboratories. This report summarizes data on BLLs in children aged 1-5 years from NHANES data collected in 1999 and children aged < 6 years from state surveillance data provided to CDC by 19 state surveillance programs during 1996-1998. The findings indicate that, despite the decreases in mean BLL among children, the problem remains concentrated on a local level. Surveillance efforts should be used to target screening efforts to communities at highest risk. SN - 0149-2195 UR - https://www.unboundmedicine.com/medline/citation/11190117/Blood_lead_levels_in_young_children__United_States_and_selected_states_1996_1999_ L2 - http://www.cdc.gov/mmwr/preview/mmwrhtml/mm4950a3.htm DB - PRIME DP - Unbound Medicine ER -